ABBOTT LABORATORIES — Director's Dealing 2020

Apr 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2020-04-21

Reporting Person: Contreras Jaime (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-21	Common shares without par value	M	46016	$44.40	Acquired	83035	Direct
2020-04-21	Common shares without par value	M	36715	$59.94	Acquired	119750	Direct
2020-04-21	Common shares without par value	M	25681	$75.90	Acquired	145431	Direct
2020-04-21	Common shares without par value	F	83226	$98	Disposed	62205	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-21	Option (right to buy)	$44.40	M	46016	Disposed	2027-02-16	Common shares (46016)	Direct
2020-04-21	Option (right to buy)	$59.94	M	36715	Disposed	2028-02-15	Common shares (36715)	Direct
2020-04-21	Option (right to buy)	$75.90	M	25681	Disposed	2029-02-21	Common shares (25681)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	22	Indirect
Common shares without par value	176217	Indirect
Common shares without par value	2624	Indirect
Common shares without par value	12081	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of April 21, 2020.

F2: Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.

F3: The reporting person disclaims beneficial ownership of all securities held by his spouse.

F4: Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.

F5: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

F6: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.